Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for SANUWAVE Health (SNWV) over the last 10 years, with Q3 2025 value amounting to -$6.1 million.

  • SANUWAVE Health's Gains from Investment Securities fell 13234.65% to -$6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 53116.4%. This contributed to the annual value of $31.4 million for FY2024, which is 22650.45% up from last year.
  • According to the latest figures from Q3 2025, SANUWAVE Health's Gains from Investment Securities is -$6.1 million, which was down 13234.65% from -$990000.0 recorded in Q2 2025.
  • In the past 5 years, SANUWAVE Health's Gains from Investment Securities ranged from a high of $19.3 million in Q3 2023 and a low of -$20.3 million during Q4 2023
  • Its 3-year average for Gains from Investment Securities is $3.5 million, with a median of $3.8 million in 2023.
  • Over the last 5 years, SANUWAVE Health's Gains from Investment Securities had its largest YoY gain of 16780.83% in 2024, and its largest YoY loss of 19727.82% in 2024.
  • SANUWAVE Health's Gains from Investment Securities (Quarter) stood at -$20.3 million in 2023, then surged by 167.81% to $13.8 million in 2024, then crashed by 144.25% to -$6.1 million in 2025.
  • Its Gains from Investment Securities stands at -$6.1 million for Q3 2025, versus -$990000.0 for Q2 2025 and $4.9 million for Q1 2025.